Sai Life Sciences IPO opens this week. GMP, price band, key dates among 10 things to know
Sai Life Sciences IPO before subscribing to the issue.
1) What is the business overview of Sai Life Sciences?
Sai Life Sciences provides end-to-end services across the drug discovery, development, and manufacturing value chain for small molecule New Chemical Entities (NCEs) to global pharmaceutical innovator companies and biotechnology firms.
2) What is the industry overview of Sai Life Sciences?
The global small molecule contract research, development, and manufacturing organization industry is forecast to reach $159 billion by 2028, comprising approximately 53% of the overall global contract research, development, and manufacturing organization industry. This growth is driven by increasing pharmaceutical and biotech research and development outsourcing, continued demand for small molecules, and a growing need for cost-effective drugs.
3) What is the current GMP of Sai Life Sciences?
According to market analysts, the current GMP of Sai Life Sciences is Rs 22, indicating a premium of 4.01% over the issue price.
4) What is the size of Sai Life Sciences IPO?
The IPO is a combination of a fresh issue of equity shares worth up to Rs 950 crore and an Offer for Sale (OFS) of up to 3.81 crore equity shares by the promoter, investor shareholders, and other shareholders.
Stock Trading
Technical Trading Made Easy: Online Certification Course
By — Souradeep Dey, Equity and Commodity Trader, Trainer
Stock Trading
Dow Theory Made Easy
By — Vishal Mehta, Independent Systematic Trader
Stock Trading
Advanced Strategies in Stock
